Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services
Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25026Q0104 in this department, oldest first.
- Nov 4, 2025 · this noticeSpecial Notice
- Dec 30, 2025Award NoticeADAPTIVE BIOTECHNOLOGIES CORPORATION · $244KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Notice of Intent to Sole-Source Requirement: The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 621511, Size Standard is $41.5 Million. The Product Service Code (PSC) is Q301. The sole-source contract will be awarded to: ADAPTIVE BIOTECHNOLOGIES CORPORATION UEI: DMW5BNQ331K9 Description of requirements: The VA Northeast Ohio… (show all)
Healthcare System (VANEOHS), Pathology and Laboratory Medicine Service (PALMS), requires molecular minimal residual disease (MRD) testing services utilizing the clonoSEQ Assay provided exclusively by Adaptive Biotechnologies. The clonoSEQ Assay is a proprietary, patented molecular test developed and performed exclusively by Adaptive Biotechnologies. Adaptive Biotechnologies is the sole source provider of clonoSEQ MRD testing within the United States. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government. The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy @ thomas.bellamy@va.gov by 3:00 p.m. EST November 12th, 2025.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same product/service code (PSC) Q301 and NAICS 621511.
Single-winner award sizes (8): middle half $243K to $3.1M, median $1.3M; range $130K to $4.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| LABORATORY CORPORATION | 4 | $13.7M | Aug 31, 2026 |
| CYTOPATH BIOPSY LAB INC | 2 | $533K | Dec 23, 2025 |
| MAYO COLLABORATIVE SERVICES, INC. | 1 | $275K | Apr 20, 2026 |
| VERACYTE LABS SD CORPORATION · $VCYT · $361.1M | 1 | $130K | Nov 19, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $VCYT reported $361.1M revenue in FY2025. The median single-winner award in these 8 past awards, $1.3M, is 0.4% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Aug 31, 2026LABORATORY CORPORATION$4.6MQ301--Reference Lab Services - BCVAMC &WCBOC
- Aug 13, 2026LABORATORY CORPORATION$2.3MQ301--Reference Lab Services - Saginaw
- Jul 17, 2026LABORATORY CORPORATION$2.7MQ301--Reference Lab Services - Detroit
- Apr 20, 2026MAYO COLLABORATIVE SERVICES, INC.$275KEsoteric Lab Testing
- Dec 23, 2025CYTOPATH BIOPSY LAB INC$146KQ301 - Thyro Seq v3 Genomic Classifier (GC) Testing
- Nov 19, 2025VERACYTE LABS SD CORPORATION$130KQ301--Decipher Prostate Testing Base- Ann Arbor, Battle Creek and Saginaw
- Oct 6, 2025CYTOPATH BIOPSY LAB INC$387KQ301--ThyroSeq v3 Genomic Classifier Richard L. Roudebush VA Medical Center Indianapolis, IN 46202
- Jun 30, 2025LABORATORY CORPORATION$4.0MQ301--Indy Reference Laboratory Testing
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 2 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.